AirSculpt Technologies, Inc.
AirSculpt Technologies, Inc.
- Market cap
- $43.67M
Your view on AIRS
Overview
What the company does, where it operates, and who runs it.
About AirSculpt Technologies, Inc.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Yogesh Jashnani
- Headquarters
- 400 Alton Road, Miami Beach, FL, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Yogesh Jashnani
- Headquarters
- 400 Alton Road, Miami Beach, FL, US
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure.
The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas.
Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for AirSculpt Technologies, Inc.. Starting points for AirSculpt Technologies, Inc.: EPS -$0.13, beta 2.28 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for AirSculpt Technologies, Inc.. Trailing twelve-month EPS for AirSculpt Technologies, Inc. stands at -$0.13. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Buy
Targets, low to high
Analyst ratings
6 ratings- Strong Buy0
- Buy3
- Hold3
- Sell0
- Strong Sell0
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | −$0.05 | −$0.03 | −$0.17 | −$0.13 |
| Lowest estimate | −$0.05 | −$0.03 | −$0.17 | −$0.13 |
| Highest estimate | −$0.04 | −$0.03 | −$0.16 | −$0.13 |
| Number of analysts | 1 | 1 | 2 | 2 |
| A year ago | $0.021 | $0.021 | −$0.191 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $31.45M | $38.66M | $146.10M | $148.26M |
| Lowest estimate | $30.77M | $36.86M | $143.21M | $145.32M |
| Highest estimate | $32.11M | $40.62M | $148.77M | $150.97M |
| Number of analysts | 4 | 4 | 3 | 3 |
| A year ago | $33.44M | $39.39M | $151.82M | — |
| Growth vs a year ago | −6.0% | −1.8% | −3.8% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for AirSculpt Technologies, Inc.. AirSculpt Technologies, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| AMNAMN Healthcare Services, Inc. | Healthcare | Medical - Care Facilities | $1.4B | ||
| AQSTAquestive Therapeutics, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $434.9M | ||
| CMPSCOMPASS Pathways plc | Healthcare | Biotechnology | $1.1B | ||
| CYHCommunity Health Systems, Inc. | Healthcare | Medical - Care Facilities | $228.5M | ||
| DRIODarioHealth Corp. | Healthcare | Medical - Specialties | $14.9M | ||
| INNVInnovAge Holding Corp. | Healthcare | Medical - Care Facilities | $1.2B | ||
| MLTXMoonLake Immunotherapeutics | Healthcare | Biotechnology | $942.1M | ||
| OFIXOrthofix Medical Inc. | Healthcare | Medical - Devices | $247.4M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| AMBDAmerican Mobile Dental Corp. | Healthcare | OTC | $85,625 | ||
| AMSAmerican Shared Hospital Services | Healthcare | AMEX | $6.7M | ||
| AONCAmerican Oncology Network, Inc. | Healthcare | OTC | $351.0M | ||
| ARDTArdent Health Partners, LLC | Healthcare | NYSE | $2.1B | ||
| ARPCArem Pacific Corporation | Healthcare | OTC | $336,555 | ||
| ASTHAstrana Health, Inc. | Healthcare | NASDAQ | $1.4B | ||
| AUNAAuna S.A. | Healthcare | NYSE | $271.0M | ||
| AVAHAveanna Healthcare Holdings Inc. | Healthcare | NASDAQ | $2.4B | ||
| BACKIMAC Holdings, Inc. | Healthcare | NASDAQ | $196,818 | ||
| BBALNew York Health Care, Inc. | Healthcare | OTC | $3,354 | ||
| BDULFBangkok Dusit Medical Services Public Company Limited | Healthcare | OTC | $10.3B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| IWMiShares Russell 2000 ETF | $76.6B in assets | 0.00% | |
| VXFVanguard Extended Market ETF | $30.2B in assets | 0.00% | |
| SCHASchwab U.S. Small-Cap ETF | $21.7B in assets | 0.00% | |
| IWOiShares Russell 2000 Growth ETF | $13.7B in assets | 0.00% | |
| IWCiShares Micro-Cap ETF | $1.2B in assets | 0.00% | |
| VTWGVanguard Russell 2000 Growth ETF | $1.4B in assets | 0.00% | |
| SMMDiShares Russell 2500 ETF | $4.1B in assets | 0.00% | |
| DFMCU.S. Micro Cap Portfolio ETF | $7.4B in assets | 0.00% | |
Largest holders first, then the funds most concentrated in AIRS.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold AirSculpt Technologies, Inc., and how their positions are changing. At a $43.7M market value, institutional positions materially move AirSculpt Technologies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by AirSculpt Technologies, Inc. executives and directors. Shares of AirSculpt Technologies, Inc. have traded between $1.53 and $12.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for AirSculpt Technologies, Inc.. Coverage tracks AirSculpt Technologies, Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of AirSculpt Technologies, Inc.